Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization.
Overview
Abstract
Background: Immune checkpoint inhibitors (ICIs) can induce immune-related adverse events (irAEs) across multiple organ systems. Although inflammatory central nervous system irAEs (CNS inflammatory irAEs) are uncommon, they are often severe. Primary CNS tumors and brain metastases have distinct immune microenvironments, yet the heterogeneity of ICI-related inflammatory CNS irAE reporting signals across tumor phenotypes remains poorly understood.
Methods: We used pharmacovigilance signal discovery, external corroboration, and transcriptomic contextualization of pre-existing brain tumor immune landscapes. We constructed an ICI-exposed cohort from the FDA Adverse Event Reporting System (FAERS) and compared inflammatory CNS irAE disproportionality signals across primary CNS tumors, brain metastases, and non-CNS solid tumors. External comparison used the Japanese Adverse Drug Event Report database (JADER). Public single-cell RNA sequencing datasets were analyzed to characterize baseline strict inflammatory and broad stress-related modules across cellular compartments, with spatial transcriptomics used as secondary descriptive visualization in brain metastasis tissue.
Results: In FAERS, inflammatory CNS irAE reporting signals suggested tumor phenotype-associated heterogeneity, with adjusted odds ratios of 1.65 (95% CI, 1.02–2.65) for primary CNS tumors and 3.12 (95% CI, 2.45–3.98) for brain metastases versus non-CNS solid tumors. Signals were stronger under a strict noninfectious phenotype and attenuated under a broad neuroinflammatory phenotype. Thyroid comparator analyses showed no comparable enrichment, whereas the myocarditis-related comparator was too sparse in the brain metastasis subgroup for meaningful inference. JADER showed a broadly similar pattern, although primary CNS tumor estimates were sparse and exploratory. Baseline single-cell analyses localized strict inflammatory module activity mainly to myeloid and T/
Conclusions: ICI-related inflammatory CNS irAE reporting signals suggested tumor phenotype-associated differences, most prominently in brain metastases. Stricter phenotype definitions appeared more specific than broader neuroinflammatory definitions. Public single-cell datasets characterized pre-existing immune-rich myeloid/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE131928, at NCBI GEO; found in the text, “Single-cell RNA sequencing analysis”
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 4 authors, 5 keywords, 11 MeSH terms, 36 references.
Cite
This paper
Song, J., He, Z., Han, C., & Hou, X. (2026). Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization. Frontiers in immunology, 17, 1866830. https://
BibTeX
@article{song2026heterog
author = {Song, Junlin and He, Zeyu and Han, Chong and Hou, Xiaohong},
title = {{Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization}},
journal = {Frontiers in immunology},
year = {2026},
month = jul,
volume = {17},
pages = {1866830},
publisher = {Frontiers Media SA},
issn = {1664-3224},
doi = {10.3389/
url = {https://
pmid = {42488653},
pmcid = {PMC13388250}
}
RIS
TY - JOUR
AU - Song, Junlin
AU - He, Zeyu
AU - Han, Chong
AU - Hou, Xiaohong
TI - Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization
T2 - Frontiers in immunology
J2 - Front Immunol
PY - 2026
DA - 2026/
VL - 17
SP - 1866830
SN - 1664-3224
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization",
"container-title": "Frontiers in immunology",
"author": [
{
"family": "Song",
"given": "Junlin"
},
{
"family": "He",
"given": "Zeyu"
},
{
"family": "Han",
"given": "Chong"
},
{
"family": "Hou",
"given": "Xiaohong"
}
],
"container-title-short":
"volume": "17",
"page": "1866830",
"DOI": "10.3389/
"PMID": "42488653",
"PMCID": "PMC13388250",
"ISSN": "1664-3224",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
8
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1172/jci.insight.199498
- Distinct immune landscapes characterize highly versus minimally invasive brain metastases.Journal: JCI insightIn common: genetics / omics, other condition, 5 references
- [2] doi:10.1016/j.neo.2024.101116
- High p16&
lt;sup& gt;INK4A& lt;/ sup& gt; expression in glioblastoma is associated with senescence phenotype and better prognosis. Journal: Neoplasia (New York, N.Y.)In common: NCBI GEO GSE131928, other condition, 2 references - [3] doi:10.1371/journal.pone.0295346
- Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.Journal: PloS oneIn common: NCBI GEO GSE131928, other condition, 3 references
- [4] doi:10.1172/jci.insight.187684
- Glycoprotein NMB mediates bidirectional GSC-TAM interactions to promote tumor progression.Journal: JCI insightIn common: NCBI GEO GSE131928, other condition, 2 references
- [5] doi:10.1038/s41419-025-07678-x
- Fusion of glioma-associated mesenchymal stem/
stromal cells with glioma cells promotes macrophage recruitment and M2 polarization via m& lt;sup& gt;6& lt;/ sup& gt;A modification of CSF1. Journal: Cell death & diseaseIn common: NCBI GEO GSE131928, other condition, 2 references - [6] doi:10.1038/s41419-024-06903-3
- ID2-ETS2 axis regulates the transcriptional acquisition of pro-tumoral microglia phenotype in glioma.Journal: Cell death & diseaseIn common: NCBI GEO GSE131928, other condition, 2 references
- [7] doi:10.3892/ol.2024.14339
- CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.Journal: Oncology lettersIn common: NCBI GEO GSE131928, genetics / omics, other condition, 2 references
- [8] doi:10.3390/biomedicines13061304 [code]
- Multi-Transcriptomic Analysis Reveals GSC-Driven MES-Like Differentiation via EMT in GBM Cell-Cell Communication.Journal: BiomedicinesIn common: NCBI GEO GSE131928, genetics / omics, other condition, 2 references
- [9] doi:10.1016/j.isci.2024.109184 [code]
- Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma.Journal: iScienceIn common: NCBI GEO GSE131928, genetics / omics, other condition, 2 references
- [10] doi:10.3390/ijms26157411
- Elevated Antigen-Presenting-Cell Signature Genes Predict Stemness and Metabolic Reprogramming States in Glioblastoma.Journal: International journal of molecular sciencesIn common: NCBI GEO GSE131928, genetics / omics, other condition, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
